Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost in the treatment of pre-eclampsia – clinical pilot study
2009-015828-28Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Dec 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of iloprost in preeclampsia, sponsored by Medical University of Vienna. Primary endpoint: Reduction of proteinuria below 0.3 g/day. Started Dec 2009; status: completed.
02
Drugs
iloprost
03
Conditions
preeclampsia
Beyond the preview
Go deeper on 2009-015828-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015828-28.